These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 9892682)

  • 1. DNA methylation in transcriptional repression of two differentially expressed X-linked genes, GPC3 and SYBL1.
    Huber R; Hansen RS; Strazzullo M; Pengue G; Mazzarella R; D'Urso M; Schlessinger D; Pilia G; Gartler SM; D'Esposito M
    Proc Natl Acad Sci U S A; 1999 Jan; 96(2):616-21. PubMed ID: 9892682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allelic inactivation of the pseudoautosomal gene SYBL1 is controlled by epigenetic mechanisms common to the X and Y chromosomes.
    Matarazzo MR; De Bonis ML; Gregory RI; Vacca M; Hansen RS; Mercadante G; D'Urso M; Feil R; D'Esposito M
    Hum Mol Genet; 2002 Dec; 11(25):3191-8. PubMed ID: 12444103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequent silencing of the GPC3 gene in ovarian cancer cell lines.
    Lin H; Huber R; Schlessinger D; Morin PJ
    Cancer Res; 1999 Feb; 59(4):807-10. PubMed ID: 10029067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GPC4, the gene for human K-glypican, flanks GPC3 on xq26: deletion of the GPC3-GPC4 gene cluster in one family with Simpson-Golabi-Behmel syndrome.
    Veugelers M; Vermeesch J; Watanabe K; Yamaguchi Y; Marynen P; David G
    Genomics; 1998 Oct; 53(1):1-11. PubMed ID: 9787072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Escape from gene silencing in ICF syndrome: evidence for advanced replication time as a major determinant.
    Hansen RS; Stöger R; Wijmenga C; Stanek AM; Canfield TK; Luo P; Matarazzo MR; D'Esposito M; Feil R; Gimelli G; Weemaes CM; Laird CD; Gartler SM
    Hum Mol Genet; 2000 Nov; 9(18):2575-87. PubMed ID: 11063717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maintenance of X- and Y-inactivation of the pseudoautosomal (PAR2) gene SPRY3 is independent from DNA methylation and associated to multiple layers of epigenetic modifications.
    De Bonis ML; Cerase A; Matarazzo MR; Ferraro M; Strazzullo M; Hansen RS; Chiurazzi P; Neri G; D'Esposito M
    Hum Mol Genet; 2006 Apr; 15(7):1123-32. PubMed ID: 16500999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of GPC3, an X-linked recessive overgrowth gene, is silenced in malignant mesothelioma.
    Murthy SS; Shen T; De Rienzo A; Lee WC; Ferriola PC; Jhanwar SC; Mossman BT; Filmus J; Testa JR
    Oncogene; 2000 Jan; 19(3):410-6. PubMed ID: 10656689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple Sp1 sites efficiently drive transcription of the TATA-less promoter of the human glypican 3 (GPC3) gene.
    Huber R; Schlessinger D; Pilia G
    Gene; 1998 Jul; 214(1-2):35-44. PubMed ID: 9651473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glypican 3 and glypican 4 are juxtaposed in Xq26.1.
    Huber R; Mazzarella R; Chen CN; Chen E; Ireland M; Lindsay S; Pilia G; Crisponi L
    Gene; 1998 Dec; 225(1-2):9-16. PubMed ID: 9931407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-resolution methylation analysis of the human hypoxanthine phosphoribosyltransferase gene 5' region on the active and inactive X chromosomes: correlation with binding sites for transcription factors.
    Hornstra IK; Yang TP
    Mol Cell Biol; 1994 Feb; 14(2):1419-30. PubMed ID: 8289817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mapping of the Simpson-Golabi-Behmel overgrowth syndrome gene (GPC3) to chromosome X in human and rat by fluorescence in situ hybridization.
    Shen T; Sonoda G; Hamid J; Li M; Filmus J; Buick RN; Testa JR
    Mamm Genome; 1997 Jan; 8(1):72. PubMed ID: 9021160
    [No Abstract]   [Full Text] [Related]  

  • 12. The IL-9 receptor gene, located in the Xq/Yq pseudoautosomal region, has an autosomal origin, escapes X inactivation and is expressed from the Y.
    Vermeesch JR; Petit P; Kermouni A; Renauld JC; Van Den Berghe H; Marynen P
    Hum Mol Genet; 1997 Jan; 6(1):1-8. PubMed ID: 9002663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentially regulated and evolved genes in the fully sequenced Xq/Yq pseudoautosomal region.
    Ciccodicola A; D'Esposito M; Esposito T; Gianfrancesco F; Migliaccio C; Miano MG; Matarazzo MR; Vacca M; Franzè A; Cuccurese M; Cocchia M; Curci A; Terracciano A; Torino A; Cocchia S; Mercadante G; Pannone E; Archidiacono N; Rocchi M; Schlessinger D; D'Urso M
    Hum Mol Genet; 2000 Feb; 9(3):395-401. PubMed ID: 10655549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glypican-3 expression is silenced in human breast cancer.
    Xiang YY; Ladeda V; Filmus J
    Oncogene; 2001 Nov; 20(50):7408-12. PubMed ID: 11704870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A small interstitial deletion in the GPC3 gene causes Simpson-Golabi-Behmel syndrome in a Dutch-Canadian family.
    Xuan JY; Hughes-Benzie RM; MacKenzie AE
    J Med Genet; 1999 Jan; 36(1):57-8. PubMed ID: 9950367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mapping of a new SGBS locus to chromosome Xp22 in a family with a severe form of Simpson-Golabi-Behmel syndrome.
    Brzustowicz LM; Farrell S; Khan MB; Weksberg R
    Am J Hum Genet; 1999 Sep; 65(3):779-83. PubMed ID: 10441586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations in GPC3, a glypican gene, cause the Simpson-Golabi-Behmel overgrowth syndrome.
    Pilia G; Hughes-Benzie RM; MacKenzie A; Baybayan P; Chen EY; Huber R; Neri G; Cao A; Forabosco A; Schlessinger D
    Nat Genet; 1996 Mar; 12(3):241-7. PubMed ID: 8589713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Large scale deletions in the GPC3 gene may account for a minority of cases of Simpson-Golabi-Behmel syndrome.
    Lindsay S; Ireland M; O'Brien O; Clayton-Smith J; Hurst JA; Mann J; Cole T; Sampson J; Slaney S; Schlessinger D; Burn J; Pilia G
    J Med Genet; 1997 Jun; 34(6):480-3. PubMed ID: 9192268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of exon/intron structure and 400 kb of genomic sequence surrounding the 5'-promoter and 3'-terminal ends of the human glypican 3 (GPC3) gene.
    Huber R; Crisponi L; Mazzarella R; Chen CN; Su Y; Shizuya H; Chen EY; Cao A; Pilia G
    Genomics; 1997 Oct; 45(1):48-58. PubMed ID: 9339360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple binding of methyl-CpG and polycomb proteins in long-term gene silencing events.
    Matarazzo MR; De Bonis ML; Strazzullo M; Cerase A; Ferraro M; Vastarelli P; Ballestar E; Esteller M; Kudo S; D'Esposito M
    J Cell Physiol; 2007 Mar; 210(3):711-9. PubMed ID: 17133344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.